---
title: "Evaluation of Provider vs. Patient Mediated Cascade Genetic Testing of First-Degree Relatives of Patients With Newly Diagnosed Colorectal Cancer"
canonical: "https://www.renown.org/clinical-trials-directory/NCT07143487"
last_updated: "2026-09-22T21:56:47Z"
---

# Evaluation of Provider vs. Patient Mediated Cascade Genetic Testing of First-Degree Relatives of Patients With Newly Diagnosed Colorectal Cancer

URL: https://www.renown.org/clinical-trials-directory/NCT07143487

Short Title: A212101

Enrollment Status: Recruiting

NCT #: [NCT07143487](https://clinicaltrials.gov/study/NCT07143487)

Specialty Area: Oncology

Condition Studied: Newly-Diagnosed Colorectal Cancer

Age Groups: Adult; Older Adult

Sex: All

Study Type: Interventional

Accepts Healthy Volunteers: No

Phase: Not Applicable

Principal Investigator: Max Coppes, MD, PhD

Complete Study Details: https://clinicaltrials.gov/study/NCT07143487

## Study Information

### Summary / Purpose

This clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relatives of patients with newly diagnosed colorectal cancer.

### Who Can Participate

- Adults 18+ years of age
- Newly diagnosed primary colorectal adenocarcinoma, Stage I to IV
- Have not received germline testing in the 2 years prior to enrollment or known hereditary colon cancer syndromes
- Must have at least 2 living first-degree relatives
- No known diagnosis of dementia or cognitive impairment

### What's Involved

- Pre-test genetic education
- Genetic testing
- Sharing your cancer diagnosis with your first-degree relatives (FDRs)
- Providing the names and phone numbers of at least two of your living FDRs who are age 18 or older
- Participants whose genetic test is abnormal with the mutation that may cause cancer will be assigned to:
  - The usual approach (Group 1) where you will contact your first-degree family members to recommend them to have genetic testing, or
  - The provider-mediated approach (Group 2) where a study team member will contact your first-degree family members to recommend and assist scheduling their genetic testing.

## Additional Information

Location: Renown Health, Office of Clinical Research

Address: 1500 E 2nd St. Reno, NV 89502

General Research: [775-982-3646](tel:775-982-3646)

Oncology Research: [775-982-5050](tel:775-982-5050)

Email: [Renown-CRD@renown.org](mailto:Renown-CRD@renown.org)
